Sung-Nan Pei Selected Research

Febuxostat

1/2017

Febuxostat-induced agranulocytosis in an end-stage renal disease patient: A case report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sung-Nan Pei Research Topics

Disease

5	Neoplasms (Cancer) 04/2024 - 08/2012
4	Hepatitis B 12/2021 - 07/2012
3	B-Cell Lymphoma (Lymphoma, B Cell) 12/2021 - 03/2010
3	Infections 12/2021 - 01/2017
3	Coronary Artery Disease (Coronary Atherosclerosis) 04/2020 - 10/2015
3	Lymphoma (Lymphomas) 01/2018 - 03/2010
2	Hepatitis 12/2021 - 03/2010
2	Multiple Myeloma 01/2019 - 03/2010
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2016 - 03/2015
2	Liver Failure 06/2015 - 03/2010
2	Myocardial Infarction 03/2009 - 08/2008
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2022
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2021
1	Iron Deficiencies 11/2021
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 07/2021
1	Triple Negative Breast Neoplasms 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Stomach Neoplasms (Stomach Cancer) 08/2020
1	Septic Shock (Toxic Shock Syndrome) 01/2020
1	Mediastinal Emphysema (Pneumomediastinum) 01/2020
1	Subcutaneous Emphysema 01/2020
1	Leukemia 01/2019
1	Ischemic Stroke 01/2018
1	Ventricular Remodeling 01/2018
1	Brain Infarction 01/2018
1	Heart Failure 01/2018
1	Diarrhea 01/2017
1	Agranulocytosis (Granulocytopenia) 01/2017
1	Renal Insufficiency (Renal Failure) 01/2017
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2017
1	Gout 01/2017
1	Exanthema (Rash) 01/2017
1	Hypertension (High Blood Pressure) 01/2016
1	Vascular Diseases (Vascular Disease) 01/2016
1	Vascular Calcification 01/2016
1	Chronic Renal Insufficiency 01/2016
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2015
1	Acute Liver Failure (Fulminant Hepatic Failure) 06/2015
1	Viremia 06/2015
1	Disease Progression 06/2015
1	Primary Myelofibrosis (Myelosclerosis) 05/2015
1	Pulmonary Tuberculosis 05/2015
1	Type 2 Diabetes Mellitus (MODY) 03/2015
1	Carcinoma (Carcinomatosis) 01/2014
1	Hepatocellular Carcinoma (Hepatoma) 01/2014

Drug/Important Bio-Agent (IBA)

6	Rituximab (Mabthera)FDA Link 10/2022 - 03/2010
3	AntibodiesIBA 12/2021 - 07/2012
2	Vincristine (Oncovin)FDA LinkGeneric 10/2022 - 01/2018
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2022 - 01/2018
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2022 - 01/2014
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2018 - 10/2015
2	Antiviral Agents (Antivirals)IBA 01/2018 - 06/2015
2	Biomarkers (Surrogate Marker)IBA 01/2016 - 10/2015
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 06/2015 - 03/2010
1	InterferonsIBA 04/2024
1	Prednisone (Sone)FDA LinkGeneric 10/2022
1	IronIBA 11/2021
1	Bevacizumab (Avastin)FDA Link 07/2021
1	Therapeutic UsesIBA 07/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2021
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2021
1	PlatinumIBA 08/2020
1	AnthelminticsIBA 01/2019
1	Sirtuin 3IBA 01/2019
1	p38 Mitogen-Activated Protein KinasesIBA 01/2019
1	thiamine triphosphorate (TTP)IBA 01/2019
1	Albendazole (Albenza)FDA Link 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Prednisolone (Predate)FDA LinkGeneric 01/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2017
1	Uric Acid (Urate)IBA 01/2017
1	Xanthine OxidaseIBA 01/2017
1	Febuxostat FDA Link 01/2017
1	C-Reactive ProteinIBA 01/2016
1	AngiotensinsIBA 01/2016
1	Angiotensin-Converting Enzyme 2IBA 01/2016
1	Nucleotide AptamersIBA 10/2015
1	OligonucleotidesIBA 10/2015
1	ruxolitinibIBA 05/2015
1	Rosiglitazone (Avandia)FDA Link 03/2015
1	Insulin (Novolin)FDA Link 03/2015
1	Cisplatin (Platino)FDA LinkGeneric 01/2014
1	von Willebrand FactorIBA 08/2012
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 07/2011
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 07/2011
1	Endothelin-1 (Endothelin 1)IBA 07/2011
1	Messenger RNA (mRNA)IBA 07/2011

Therapy/Procedure

12	Therapeutics 12/2021 - 01/2008
8	Drug Therapy (Chemotherapy) 10/2022 - 01/2008
5	Cell- and Tissue-Based Therapy (Cell Therapy) 04/2020 - 08/2008
3	Transplantation 01/2019 - 03/2009
2	Renal Dialysis (Hemodialysis) 01/2016 - 03/2010
1	Time-to-Treatment 01/2021
1	Adjuvant Chemotherapy 08/2020
1	Mechanical Ventilators (Ventilator) 01/2020
1	Stem Cell Transplantation 01/2019
1	Catheters 01/2018
1	Precision Medicine 10/2015